Other

The case for maintaining current regulations on I-131 therapy

Two articles in the June issue of The Journal of Nuclear Medicine make a case for maintaining current U.S. Nuclear Regulatory Commission (NRC) regulations on the release of patients who undergo radioactive iodine treatments ...

Oncology & Cancer

Incidence of thyroid cancer on the rise

The incidence of thyroid cancer has tripled in the past three decades, yet the reason for this is not clear. Dr. David Goldenberg, chief of otolaryngology and head and neck surgery at Penn State Health Milton S. Hershey Medical ...

Surgery

Remote-control surgery grows, despite inconclusive evidence

Chubby, pink and anesthetized into unconsciousness and paralysis, 16-week-old Ian Lund was a small bump under blue drapes on an operating table at University of Chicago Medicine. Perched above him was a robot, with arms like ...

Oncology & Cancer

U.S. incidence of thyroid cancer plateaued in 2009

(HealthDay)—From 2009 to 2016, the incidence of thyroid cancer reached a plateau and possibly started to decline, according to a research letter published in the Dec. 24/31 issue of the Journal of the American Medical Association.

Oncology & Cancer

Diabetes linked to numerous cancers in large Chinese study

A new Journal of Diabetes study from China, which has the highest number of people with diabetes among all countries, found that type 2 diabetes was linked with an elevated risk of 11 types of cancer in men and 13 types of ...

Medications

Breakthrough alpha-ray treatment of cancer without external radiation

For many years, radioactive iodine which emits beta rays has been used for treatment of thyroid cancer. Generally, 5-year survival rates may exceed 90%. However, some thyroid tumors become resistant to iodine treatment ("iodine-refractory"), ...

page 9 from 34